Tranexamic Acid in Total Joint Arthroplasty: The Endorsed Clinical Practice Guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society

Hip and knee arthroplasties are routine orthopaedic procedures commonly associated with acute postoperative anemia, and in many cases requires an allogeneic or autologous blood transfusion. Several techniques have been used to limit postoperative blood loss and risk of transfusion. Tranexamic acid (TXA) is an antifibrinolytic agent that has fundamentally changed blood management in total joint arthroplasty (TJA) by making transfusion an infrequent event.

Source: The Journal of Arthroplasty - August 6, 2018 Category: Orthopaedics Authors: Y.A. Fillingham, D.B. Ramkumar, D.S. Jevsevar, A.J. Yates, S.A. Bini, H.D. Clarke, E. Schemitsch, R.L. Johnson, S.G. Memtsoudis, S.A. Sayeed, A.P. Sah, C.J. Della Valle Tags: Review Article Source Type: research